Delaware
(State
or Other Jurisdiction
of
Incorporation)
|
000-30929
(Commission
File Number)
|
13-4087132
(IRS
Employer Identification No.)
|
£
|
Written
communications pursuant to Rule 425 under the Securities
Act.
|
£
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange
Act.
|
£
|
Pre-commencement
communications pursuant to Rule 14d-2b under the Exchange
Act.
|
£
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange
Act.
|
Keryx
Biopharmaceuticals, Inc.
(Registrant)
|
||
|
|
|
Date: March 1, 2006 | By: | /s/ Ronald C. Renaud, Jr. |
Ronald C. Renaud, Jr. |
||
Senior Vice President, Chief Financial Officer, Secretary and Treasurer |
Exhibit
Number
|
Description |
99.1 |
Press
Release dated March 1, 2006.
|